---
figid: PMC10341728__ijms-24-10652-g007
figtitle: Schematic model
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC10341728
filename: PMC10341728__ijms-24-10652-g007.jpg
figlink: /pmc/articles/PMC10341728/figure/F7
number: F7
caption: Schematic model. CCL2 promotes ovarian cancer progression through the MEK/ERK/MAPP3K19
  signaling pathway
papertitle: CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19
  Signaling Pathway
reftext: Wei Liu, et al. Int J Mol Sci. 2023 Jul;24(13).
year: '2023'
doi: 10.3390/ijms241310652
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: ovarian cancer | CC-chemokine ligand 2 | tumor progression | MAPK/ERK pathway
  | mitogen-activated protein three kinase 19
automl_pathway: 0.933235
figid_alias: PMC10341728__F7
figtype: Figure
redirect_from: /figures/PMC10341728__F7
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC10341728__ijms-24-10652-g007.html
  '@type': Dataset
  description: Schematic model. CCL2 promotes ovarian cancer progression through the
    MEK/ERK/MAPP3K19 signaling pathway
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CCL2
  - MAP2K2
  - MAP2K1
  - MAP2K7
  - MAPK3
  - MAPK1
  - MAP3K19
  - cancer
  - Ovarian cancer
---
